The rate of death from asthma in the United States has been increasing
over the last decade, but such deaths still remain uncommon. Mortalit
y rates differ markedly by region and ethnicity, and case-fatality rat
es are highest in black men living in inner cities. In general, patien
ts in greatest jeopardy are those with severe, unstable disease who ar
e not being objectively monitored; however, death can occur in anyone
ii the attack is intense enough. Sudden catastrophic episodes of asthm
a occur but are very rare. Failure to recognize the seriousness of the
terminal episode or to treat the episode appropriately remains the ch
ief contributing cause of poor outcome. Little compelling evidence sho
ws that adverse effects of medications play much of a role in asthma-r
elated death. The disease characteristics that place patients at risk
remain inadequately defined. Of those suggested, only a history of rec
urrent hospitalization and the need for ventilatory assistance are spe
cific enough to be helpful. These characteristics, however, are found
in only 36% and 6% of cases, respectively; thus, their absence is of n
o Value in assessing risk. The prognosis after a near-fatal episode of
asthma is poor, and approximately 10% of patients die in the year aft
er the event. Given the current state of knowledge, it is wise to view
all exacerbations of asthma that last longer than a few days as poten
tially fatal and to treat them accordingly. This is especially true in
patients who have previously had a severe episode of asthma.